|
PF-23583 |
GLUCONATO DE CLORHEXIDINA LAFOFA 0.5% Solucion Topica |
2005-11-23 |
|
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-23584 |
GLUCONATO DE CLORHEXIDINA LAFOFA 0.10% Solucion Topica |
2005-11-23 |
|
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-23586 |
CETRIMIDA CON GLUCONATO DE CLORHEXIDINA LAFOFA 0.5-0.05 % Solucion Top |
2005-11-23 |
|
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-23587 |
CETRIMIDA-GLUCONATO DE CLORHEXIDINA LAFOFA 0.3-0.03% Solucion Topica |
2005-11-23 |
|
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-23589 |
CLORURO DE BENZALCONIO LAFOFA 0.10% Solucion Topica |
2005-11-23 |
|
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26712 |
CLOFIL 0.5 % solución oftálmica |
2011-07-24 |
|
Nyal Pharmaceuticals |
Guatemala
|
Nyal Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26708 |
CLOMET Solución oftálmica |
2011-07-24 |
|
Nyal Pharmaceuticals |
Guatemala
|
Nyal Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26750 |
NAFAZOLINA 0.1% Nyal Ssolución Oftálmica |
2006-08-03 |
|
|
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26743 |
HIDROXIPROPILMETILCELULOSA 0.3% Nyal Ssolución Oftálmica |
2006-07-30 |
|
|
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26707 |
CLORANFENICOL 1% Nyal Ssolución Oftálmica |
2006-07-24 |
|
|
Guatemala
|
Distribuidora Quimicos Varios, S.A. |
Laboratorio Formulas Farmaceuticas S.A. Lafofa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|